Objective: The aim of the study was to assess (i) a group of patients with established intracranial pressure (ICP) sensor in severe brain injuries scoring 3 points of Glasgow Coma Scale, (ii) mortality and survival of the patients within periods of 7, 30, 180 and 270 days; and (iii) predictive value of intracranial pressure and cerebral perfusion pressure for short and long-term survival of patients with traumatic brain injury. Material and methods: The group consisted of 61 patients with trauma brain injury scoring 3 points of Glasgow Coma Scale, continuously monitored for intracranial pressure cerebral perfusion pressure at the Intensive Care Unit setting in Nové Zámky. Follow-up period was between 7 and 270 days. Measured values and other recorded data were analysed using methods of descriptive and inferential statistics. Results: ICP values below 20 mmHg were associated with a signifi cantly lower risk of death of an individual patient at particular time. Accordingly, cerebral perfusion pressure values above 70 mmHg during 0-2 days were associated with a signifi cantly higher long-term survival. Overall mortality rates within 30 days showed no peaks on survival curves. In the periods of 0-7 days, within 30 days, and between 30 and 180 days we recorded 24, 51 and 2 deaths, respectively. In the period between 180 and 270 days, mortality was zero. Conclusion: The survival of trauma brain injury patients depends on the speed and quality of pre-hospital care and adequate follow-up treatment at specialized intensive care units. High levels of intracranial pressure and low cerebral perfusion pressure values in the early period after brain injury are closely related to mortality of patients within 30 days. Intracranial pressure monitoring may help to avoid problems and allow intervention before they become life-threatening (Tab. 4, Fig. 4, Ref. 23). Text in PDF www.elis.sk.
In 1960´s, Lundberg published works dealing with intracranial pressure (ICP) monitoring, which were followed by establishing standardized terapeutic procedures for ICP measurement that were considered to reduce the extent of secondary post-traumatic brain injury (1) .
In 1996, for the fi rst time, uniform procedures for diagnosing and treating severe craniocerebral injuries were suggested and published by American Association of Neurological Surgeons and Trauma Brain Injury Foundation (2) .
Brain injury is frequently associated with polytrauma, which greatly affects the survival of patients. The most common causes of brain injuries are traffi c accidents, falling from heights, gunshot wounds, and work-related accidents.
Among the experts, there is a common perception of lack of defi nite data on the benefi t from ICP monitoring because monitoring is not routinely performed in most of intensive care unit (ICU) centres worldwide. The main reason is that ICP monitoring is not without risks and errors such as incorrect probe placement, collapsed ventricular areas, the possibility of intracranial haemorrhage, or mechanical failure of ICP sensor (3) . The risk of infection associated with insertion of the sensor is 6-11 % in case of using sensor for over 6 days (3, 4) . The incidence of bacterial colonization of intraparenchyme sensor with no clinical signs of infection is 10 % (4). However, it was reported that mortality and clinical outcome in severe brain injury did not differ signifi cantly between the groups with and without sensor (5) .
The aim of this prospective study was to verify the predictive value of the dynamics of ICP and cerebral perfusion pressure (CPP) on survival in patients with severe trauma brain injury (TBI) in both short and long term.
Patients and methods
In this prospective and comparative study, we have analysed clinical data of all patients with craniocerebral trauma who were hospitalized at our clinic between 1.1.2007 and 31. 12.2010 . The patients were transported to the clinic either directly from the scene of an accident or immediately after having been diagnosed with craniocerebral trauma in another hospital. All these patients were in coma, scored GCS 3, and in need of lung ventilation and urgent neurosurgical intervention. The patients admitted from the scene had immediately taken CT examination. According to the CT result the patient underwent neurosurgical intervention or conservative treatment that included insertion of ICP sensor. The monitoring of ICP and CPP was being done for 7 days as long as the patient survived. Of 61 patients of the cohort group, 40 patients underwent neurosurgical intervention. CT scan was repeated in 12-24 hours after surgery. In case of high ICP values with no response to treatment, CT was performed immediately. Examination was performed within 12 hours from the surgery and re-examination according to the outcome of previous one or according to the clinical condition. The study was approved by the Ethics Committee of Faculty Hospital in Nove Zamky. Methods of monitoring and clinical procedures were used as follows: -Insertion of ICP sensor, continuous measurement of ICP, CPP, body temperature -Continuous invasive measurement of arterial pressure (AP) -Regular measurement of central venous pressure -Regular evaluation of GCS, neurological status -Evaluation of period of hospitalisation, lethality -Evaluation of neurological status by GOS after 7, 30, 180 and 270 days. These parameters used for evaluating the parameters of neurological status: GCS, GOS, ICP, as well as those of hemodynamics: CPP and mean arterial pressure (MAP).
For continuous ICP monitoring we used a CODMAN parenchymatose sensor (Johnson and Johnson) that was connected to a calibrated bed-side monitor of vital functions.
Statistical analysis
Clinical data of patients (n=61) were tested for normality using a Shapiro-Wilk test. The normally distributed characteristics are described as the mean ± standard deviation (SD). Alternatively we report median with the lower and upper quartiles. For categorical variables we indicate absolute or relative (%) frequencies. Unpaired test was used for testing for differences between the group of dead (D, n=53; 86.9 %) and survived patients (S, n=8; 13.1 %) in the selected normally distributed variables at the given time. Otherwise, we used a nonparametric Mann-Whitney U test. Categorical variables were tested with a test for two binomial independent proportions.
The assumption that ICP and CPP are mutually correlated was confi rmed with simple linear regresion and Pearson correlation coefi cient (r). Dynamics of ICP and CPP changes in time (ICP and CPP time plots) in D and S groups were tested with one-way analysis of variance (ANOVA) with replication. Differences between the time-course curves for D and S groups were tested on the null hypothesis whether all data sets share the same parameters. The curves were compared with the extra-sum-of-squares F-test yielding a P value for nested model.
The relationships between potential predictors and survival were analysed by a multiple logistic regression. Clinically relevant predictors are characterised by OR (odds ratio value), which express the chance of survival for a unit change in the given characteristics. The quality of model was established by goodness-of-fi t chi 2 test whilst the signifi cance of the whole model by likelihood ratio chi 2 -test. Survival rates in both investigated D and S groups were estimated with unconditional Kaplan-Meier survival method and characterised by the median of survival together with respective 95 % confi dence intervals (95 % CI). Differences between the plots of survival for both D and S groups were tested by log-rank test. Results are presented as respective survival plots and betweengroup survival differences were examined by long-rank test in Peto-Prentice modifi cation.
All p values cited are two-sided alternatives; differences resulting in a p value of less or equal to 0.05 were declared statistically signifi cant (6, 7) .
For statistical analysis, we employed the software StatsDirect® v.2.7.8 (StatsDirect Sales, Sale, UK) and GraphPad Prism 5 (GraphPad Software, San Diego, CA, USA).
Results

Characteristics of the patients and descriptive statistics
A total of 61 patients were processed in the given period, with female gender proportion (11; 18 %) signifi cantly different from that of male gender (50; 82 %), (p<0.0001). This difference can be unequiv- ocally attributed to the inherent heterogeneity in human behaviour, i.e. to more frequent risk taking among men than among women. Eight patients (subgroup S, 13.1 %), survived the period of 270 days, all being of male gender. Fifty three patients died (subgroup D; 86.9 %); 42 men and 11 women.
The age distribution of patients has exhibited a bimodal shape, which clearly indicates two subpopulations with a point of separation at about 35y (Fig. 1 ). This distribution plot consists of two approximately normal distributions (tested by a Shapiro-Wilk test), the fi rst maximum is between 22-23 y and the second in 54 y (Tab. 1).
Medians, as representative values of age in subgroups D and S are not signifi cantly different from values that characterised the whole group of patients (T). Bimodality can be attributed to the same cause that we have suggested for the uneven proportion of genders.
Analysis of recorded ICP and CPP values
Since the calculation of CPP is based on ICP value, fi rst we have tested the tightness of the relationship between ICP and CPP and, thus the reliability of predictions of CPP from ICP. Given that the area of clinical interest has been focused on the early period after the accident, we present an analysis of averaged values of ICP and CPP from zero to second day from injury. Because of the high mortality within the fi rst 7 days and consequential rapid decrease in number of patients in sample, this model estimate is most accurate for prediction, i.e. with the narrowest 95% prediction interval (Fig. 2) . We confi rmed a high degree of negative correlation (r=-0.77; p<0.0001). Regression function for prediction of CPP is expressed by equation (1):
The dynamics of the monitored ICP and CPP values in the early period after injury is reported in Table 2 , separately for patients who did not (group D) and did survive (group S) the period of 180 days. ICP and CPP values represent a mean value of all measurements taken from the patients surviving the given day. Betweengroup differences in ICP and CPP recorded in the early period after injury (during the fi rst two days) were signifi cant (p<0.05). Since mortality in the time frame of 7 days from traumatic event is high and the sharply declining number of patients in the sample compromises the power of testing the differences, reliable estimates of the differences between groups D and S in later periods can only be obtained on the extended database of patients. However, the comparison of curves as a whole on a statistical basis using nonlinear fi tting and extra-sum-of-squares F-test yielded different bestfi t values of the model parameters and P value of less than 0.0001, respectively. These results indicate that the differences between the curve profi les for D and S groups were big enough to distinguish the groups as different with respect to the recorded ICP and CPP.
Notably, in the fi rst two days, the plots of time records of ICP values in groups D and S show different profi les (Fig. 3a) . This divergence is not refl ected in CPP profi les (Fig. 3b) . Presumably the reason is that CPP is a complex parameter composed of two measurements taken from a patient, each of them bringing specifi c information about the current patient`s condition (2) .
Our results (Tab. 2) did confi rm the suggestions made by other groups of investigators (8) that ICP values above 20 mmHg have a huge negative impact on the survivability of brain-injured patients. In order to verify this hypothesis on our sample, we stratifi ed the patients into two subgroups, one with an initial ICP (ICP in ) less than 20 mmHg (denoted as 0) and the other with that greater than or equal to 20 mmHg (denoted as 1). Although with low value of probability (p=0.11), we found that the proportions of patients between D and S groups (Tab. 3) were not signifi cantly different. This indicates that there is the possibility of type-two error, i.e. that the low number of patients in group S precludes the revealing existing difference. Despite the fact that we found a high degree of relative risk of death in patients with ICP above 20 mmHg (OR=3.6), we have to consider this result as inconclusive. Therefore, it is advisable to proceed, and extend the database of TBI patients.
Time courses of day-averaged ICP and CPP during the whole Table 4 .
Analysis of the impact of ICP and CPP on the patient mortality
With a logistic regression tool, we fi rst verifi ed whether the average ICP or CPP monitored over a period of 0-2 days from the accident would contribute signifi cantly to the prediction of mortality. We found that CPP is a stronger predictor of the outcome (death within 180 days from the traumatic event) than ICP (p=0.0007 vs 0.32, respectively). The overall model of prediction was highly signifi cant (p<0.0001), and odds ratio below unit (OR=0.86; 95% CI: 0.79-0.94) is confi rming the expected negative relationship between CPP value and risk of death. Qualitatively, the same result was obtained for the model with mean CPP for the whole monitoring period (maximum 7 days for each patient). We also proved that neither age nor gender is a signifi cant predictor (p=0.79 and 0.99, respecively). Therefore, it does not make sense to include them into the predictive model.
Survival rates in the brain-injured patients stratifi ed according to ICP values at admission
Differences in survival rates between subgroups ICP in 1 and ICP in 0 were analysed using Kaplan-Meier survival method. Kaplan-Meier`s estimate of median survival in the whole sample investigated in period 2007-2010 was 10 days (95% CI: 7.4-12.5). For the patients with ICP in above 20 mmHg (group 1), the median survival time was 4 days (95% CI: 1.2-6.8), and for those with ICP in below 20 mmHg (group 0) it was 12 days (95% CI: 9.6-14.4). This between-group difference in survival (Fig. 4) was highly signifi cant (p<0.0001). Hazard ratio for ICP in 1 compared to ICP in 0 amounted to 2.3 (95% CI: 1.14-4.60).
We can conclude that the initial ICP value below 20 mmHg was associated with a signifi cantly longer survival in patients with brain injury.
Discussion
Numerous investigations have shown that raised ICP and a fall in arterial pressure in TBI patients are associated with a poor prognosis (8, 9) . Raised ICP contributes to inadequate CPP (less than 70 mmHg), which has been shown to be a major factor in high mortality of patients, and in addition, the advances in the effective treatment of high ICP have been shown to lead to a decline in mortality rates (10) . Thus, the assessment of CPP is vital and possible, either by measurement of both ICP and MAP, or by measuring MAP and making a reasonable estimate for ICP. Therefore it would be optimal to have a possibility of precise ICP measuring. The fi rst reference to the clinical use of continuous monitoring of intracranial pressure has emerged in 1960´s (11) . Obviously, the understanding of principles of ICP measurement is an important prerequisite for its effective and safe clinical use. At present, guidelines for the indications of ICP monitoring do exist, and they have become a recommended procedure, particularly in the management of patients with acute coma due to severe brain injury, or it is assumed that along with the introduction of ICP monitoring, mortality related to brain injuries has signifi cantly decreased (5, 12) . Nevertheless, ICP monitoring is still considered to be an invasive tool with the risk of developing additional serious complications (12) reported in our previous work (13) .
Tab. 3. Overall mortality after 270 days according initial ICP during days 0-1 (fi rst 24 hours).
Day
Even though we have failed to prove a signifi cant difference in 30-day survival between ICP-monitored and not monitored patients (13) , the fi ndings have pointed to the notion that the patients with ICP values below 20 mmHg were at reduced risk of death, or vice versa, the levels above 20 mmHg signifi cantly increased the risk of death within 30 days after brain traumatic event. Therefore, in the present study we have analysed clinical data and outcomes of 61 ICP-monitored patients in detail. The median survival of the investigated sample that was followed for up to 270 days, was 10 days. Among 61 patients, 24 patients died within the fi rst 7 days, and 51 patients died in the period of 30 days from the injury. Between day 30 and day 180, only two patients died, and between day 180 and day 270, no death was observed. With the number of patients in the database being still relatively low, the counts of events (deaths) in single times do not allow for more reliable estimate of the survival rates for the specifi ed times. We certainly recommend continuing the study, and gathering more data.
The main clinically relevant fi nding in our study was the signifi cantly higher survival rate of patients with ICP below 20 mmHg with median survival of 12 days, in comparison with only 4 days for those with ICP equal or above 20 mmHg. A logistic regression analysis showed that average values of ICP and CPP recorded in the period of 0-2 days from the accident contributed to the prediction of mortality within 180 days after injury. We found that CPP is a stronger and statistically signifi cant predictor of the outcome (death within the given period) than ICP. Obviously, the CPP value, which is defi ned as the difference between mean arterial pressure and intracranial pressure, conveys more specifi c and complex information about the patient`s current condition. To estimate a patient`s CPP reliably we need to know the patient`s ICP as precisely as possible. ICP monitoring provides the only sure way of confi rming intracranial hypertension. If increased ICP is not present, the treatment potentially dangerous for that patient can be avoided. If the patient is in acute coma or sedated, the conventional neurological examination is useless. It is then that ICP monitoring provides a means of determining the patient`s CPP and index of cerebral function (14) . Thus we support the view that if hypertension is suspected, present, or persistent, a continuous measurement of ICP provides an early opportunity of assessing whether therapy works, as well as allows the team caring for the patient to quickly and effi ciently respond to elevations in ICP to various stimuli, or switch to an alternative therapy if the treatment is ineffective. Namely, continuous ICP monitoring allows taking control CT scan early enough, and deciding between neurosurgical or aggressive conservative treatment focused on effective reduction in ICP. There is a relation between ICP, CPP and MAP (2), namely if ICP is raised, a fall in blood pressure must be avoided or treated quickly to maintain MAP values at levels that would keep CCP above 70 mmHg. As we have shown in Figure 3a , ICP values above the critical value of 20 mmHg were associated with a poor cerebral outcome and consequently with death. Just as maintaining low ICP, it is important to prevent a fall in CPP below 70 mmHg, as we have found out that decreased CPP shortly after injury signifi cantly distinguished the group of non-surviving patients from those surviving the period of 180 days (Fig. 3b) . A novel fi nding in our work is the evidence that according to the current data statistical analysis (Fig. 4) , the predictive value of CPP dynamics recorded in the fi rst 24-48 hours after the accident was higher than that of ICP, although these values are interrelated (1) . This supports the importance of CPP maintenance as stressed by other studies, although some authors suggest that CPP values under 60 mmHg may still be suffi cient to ensure a good survivability in some patients with good CNS autoregulation as long as the required monitoring of cerebral oximetry and brain metabolism is provided (15) . Because we did not use cerebral oximetry, we have preferred to set the secure threshold at 70 mmHg in order to prevent potential cerebral ischaemia resulting from lower levels of ICP. According to Guidelines for the Management of Severe TBI, the critical survival limits of CPP are between 50-60 mmHg (16) . Balestri et al (17) have set the cut-off point at 60 mmHg and reported a signifi cantly increased mortality when CPP values fell below that value. Accordingly, maintaining CPP above 60 mmHg signifi cantly raised the survival rates of patients. Contrary to expectations, CPP values above 95 mmHg did not improve further the survival of patients with craniocerebral trauma in their study. White and Venkatesh also expressed an opinion that maintaining CPP between 50 and70 mmHg is acceptable providing that cerebral oximetry monitoring is also performed, however, they stress that keeping CPP in the accepted range is just one aspect of complex trauma care at ICU (18) . Mortality of patients with severe brain injury and GCS less than 8 points still remains high. The reported data in prospective and retrospective studies range from 50 % to 100 %. Chamoun et al have found 49.2 % mortality among 189 patients with GCS of 3 (19) . Fearnside et al report a 65 % mortality in patients with craniocerebral trauma scored GCS 3 (20) . Further, in their 2006 retrospective study, Tien et al published an overall mortality of 76.8 %, however, all patients with severe brain injury and haemorrhage died (21) . Similarly, high mortality rates of 89 % and 64 % were found in a study involving 111 patients with CNS haemorrhage and epidural haematoma carried out by Kotwica et al (22) , and in that involving 117 patients and carried out by Waxman et al (23) , respectively. With GOS=1, 10 patients survived, with GOS=2, 3 of them (23) .
Apparently, the above mentioned results and published outcomes indicate that it is highly desirable to have a tool that would be able to distinguish reliably the patients predisposed to trauma treatment failure. Presumably a combination of signifi cant predictors of the primary outcome (survival) measured in the early stages creates simple predictive models that allow identifying the most endangered patients. The reliability of these models can be increased by extending the patient database. A major limit of this prospective study was a low number of eligible patients, which does not allow for better-founded conclusions. Nevertheless, the assets possessed in our study include the prospective character, longer period of collecting cases (4 years) and longer follow-up of patients after their release from hospital care (180-270 days). Our results have indicated that ICP and CPP were major predictors of early and late mortality rates in severe brain injury (among patients with GCS of 3). In conclusion, we feel it worthwhile to comment on our observation of higher prevalence of TBI in male gender and that of a two-peak (bimodal) distribution for age at brain trauma occurence, which is interesting from an epidemiological point of view. Both observations represent a knowledge base for recognising subpopulations that are at greater risk of death from head trauma. With such high mortality rates among brain-injured patients, there is an obvious and urgent need to pursue effective strategies and educational programs that can reduce risk-taking behaviours, and thus prevent serious injuries from occurring. The latter fi nding strengthens the point that reliable predictive models based on both, clinical and epidemiological data, would be of great value in developing these strategies and programs. We hope this fi nding provides the epidemiologists, especially those working in trauma prevention, with ideas about how to incorporate this information into their work.
Conclusion
The aim of this prospective clinical study was to determine, whether improving the management of a comprehensive neurointensive treatment based on monitoring the intracranial pressure would positively affect the clinical course and outcome, as well as increase the chances for patients to return to society with as little permanent disability as possible. The mortality of severe TBI (GCS 3) remains very high. Most patients die in two frame windows, either shortly after the causing event, or in 30 days from it. High level of intracranial pressure (ICP >20 mmHg) and low cerebral perfusion pressure (CPP <65 mmHg), which cannot be effectively treated at ICU, are the main indicators of poor outcome in brain-injured patients. Low value of cerebral perfusion pressure (CPP <65 mmHg) during the fi rst two days is a signifi cant predictor of early and late mortality rates, and thus a better candidate for developing a predictive risk model for outcomes after brain injury. Since our analysis was confronted with a discrepancy between required and available data, we recommend further data gathering to allow for sound evaluation of ICP-monitoring benefi ts for traumatic brain injury patients.
